A 22-year-old man comes to the physician for a follow-up evaluation for chronic lower back pain. He has back stiffness that lasts all morning and slowly improves throughout the day. He has tried multiple over-the-counter medications, including ibuprofen, without any improvement in his symptoms. Physical examination shows tenderness over the iliac crest bilaterally and limited range of motion of the lumbar spine with forward flexion. The results of HLA-B27 testing are positive. An x-ray of the lumbar spine shows fusion of the lumbar vertebrae and sacroiliac joints. The physician plans to prescribe a new medication but first orders a tuberculin skin test to assess for the risk of latent tuberculosis reactivation. Inhibition of which of the following is the most likely primary mechanism of action of this drug?

Inosine monophosphate dehydrogenase

An 85-year-old woman presents to her physician with complaints of significant weakness and weight loss. She recently has been diagnosed with stage IV breast cancer for which she currently is receiving treatment. She mentions that, despite taking a diet rich in protein and calories, she continues to lose weight. On physical examination, her vital signs are stable, but muscle wasting is clearly evident in her upper limbs, lower limbs, and face. The physician explains to her that her advanced cancer is the most important cause for the weight loss and muscle wasting. This cachexia is mediated by the proteolysis-inducing factor released from cancer cells. Which of the following effects is produced by this factor?

Activation of hormone-sensitive lipase in adipose tissue

Suppression of the appetite center in the hypothalamus

Increased release of tumor necrosis factor (TNF) from macrophages

A 31-year-old woman scrapes her finger on an exposed nail and sustains a minor laceration. Five minutes later, her finger is red, swollen, and painful. She has no past medical history and does not take any medications. She drinks socially with her friends and does not smoke. The inflammatory cell type most likely to be prominent in this patient's finger has which of the following characteristics?

Dramatically expanded endoplasmic reticulum

Large cell with amoeboid movement

Dark histamine containing granules

A biology student is studying apoptosis pathways. One of the experiments conducted involves the binding of a ligand to a CD95 receptor. A defect of this pathway will most likely cause which of the conditions listed below?

Autoimmune lymphoproliferative syndrome

A 12-year-old boy admitted to the intensive care unit 1 day ago for severe pneumonia suddenly develops hypotension. He was started on empiric antibiotics and his blood culture reports are pending. According to the nurse, the patient was doing fine until his blood pressure suddenly dropped. Vital signs include: blood pressure is 88/58 mm Hg, temperature is 39.4°C (103.0°F), pulse is 120/min, and respiratory rate is 24/min. His limbs feel warm. The resident physician decides to start him on intravenous vasopressors, as the blood pressure is not responding to intravenous fluids. The on-call intensivist suspects shock due to a bacterial toxin. What is the primary mechanism responsible for the pathogenesis of this patient's condition?

Release of tumor necrosis factor (TNF)

Inactivation of elongation factor (EF) 2

Inhibition of acetylcholine release

Degradation of lecithin in cell membranes

A research team discovers a novel bacterial toxin that causes severe hypotension in infected patients. In vitro studies show the toxin ADP-ribosylates a specific amino acid on Gq alpha subunits, preventing their activation by GPCRs. Patients develop hypotension despite elevated levels of vasopressin, angiotensin II, and endothelin-1. Synthesize the pathophysiological mechanism explaining why multiple vasopressor hormones fail to maintain blood pressure in these patients.

ADP-ribosylation of Gq prevents PLC activation, blocking IP3-mediated calcium release and vascular smooth muscle contraction

The toxin depletes intracellular ATP preventing myosin-actin interaction

The toxin prevents receptor binding of vasopressor hormones through allosteric inhibition

ADP-ribosylation increases cAMP levels causing smooth muscle relaxation

The toxin activates Gi proteins causing excessive vasodilation that overwhelms vasoconstrictor signals

NF-κB signaling for USMLE Step 1: High-Yield Biochemistry Lessons

NF-κB Overview - The Cell's First Responder

NF-κB signaling: canonical and non-canonical pathways

A rapid-acting transcription factor central to immunity, inflammation, and cell survival.
Normally sequestered in the cytoplasm in an inactive state, bound to its inhibitor, IκB.
Activated by a vast range of stimuli, including:
- PAMPs: LPS (via TLRs)
- Pro-inflammatory cytokines: TNF-α, IL-1

⭐ High-Yield: Overactivation of NF-κB is a key factor in the pathogenesis of septic shock (due to massive cytokine release) and contributes to many chronic inflammatory diseases like rheumatoid arthritis and inflammatory bowel disease.

Canonical Pathway - The Main Activation Route

Trigger: Pro-inflammatory cytokines (e.g., TNF-α, IL-1), antigens, or Pathogen-Associated Molecular Patterns (PAMPs).
Resting State: NF-κB (typically p65/p50 heterodimer) is sequestered in the cytoplasm, bound to its inhibitor, IκBα.
Activation Cascade:
- Signal binding activates the IκB Kinase (IKK) complex.
- IKK phosphorylates IκBα, marking it for ubiquitination and proteasomal degradation.
- 📌 In Kase of Krisis, Inκrease Burning (IKK phosphorylates IκB).
- Freed NF-κB translocates to the nucleus, binding to κB sites on DNA to initiate gene transcription.

⭐ The pro-inflammatory cytokines TNF-α and IL-1 are potent activators of the canonical NF-κB pathway, a central mechanism in acute inflammation and sepsis.

Clinical Relevance - Disease & Drug Targets

Overactive NF-κB is a key driver in many human diseases due to its pro-inflammatory and pro-survival signaling.
- Chronic Inflammatory Disorders: Implicated in Rheumatoid Arthritis, Inflammatory Bowel Disease (IBD), and psoriasis.
- Cancer: Contributes to oncogenesis by promoting cell proliferation, angiogenesis, and metastasis while inhibiting apoptosis.
Pharmacological Inhibitors as Drug Targets:

Drug Class	Mechanism on NF-κB Pathway	Clinical Example
Glucocorticoids	Upregulate the gene for IκBα, enhancing its inhibitory effect.	Prednisone
Proteasome Inhibitors	Block IκBα degradation, preventing NF-κB nuclear translocation.	Bortezomib
NSAIDs (High-Dose)	Aspirin can inhibit IκK activity, reducing phosphorylation of IκBα.	Aspirin

High‑Yield Points - ⚡ Biggest Takeaways

NF-κB is a master transcription factor for the inflammatory response.

In its inactive state, it is sequestered in the cytoplasm by its inhibitor, IκB.

Activation by signals like TNF-α or IL-1 leads to phosphorylation of IκB by the IKK complex.

Phosphorylated IκB is targeted for ubiquitination and proteasomal degradation.

This releases NF-κB, allowing it to translocate to the nucleus and activate gene transcription.

Aberrant NF-κB signaling is a hallmark of many chronic inflammatory diseases and cancers.

Continue reading on Oncourse

CONTINUE READING — FREE

or get the app

App Store|Google Play

NF-κB signaling